Post

Flagship Pioneering and ProFound link for obesity therapies

Flagship Pioneering and ProFound Therapeutics have entered a partnership to develop new therapeutics for the treatment of obesity. The collaboration marks …

GSK and Ochre Bio link to explore liver disease drivers

GSK has entered into a multi-year data licence agreement with Ochre Bio, aiming to advance the understanding of liver disease. GSK …

Alzheon secures $100m to advance Alzheimer’s disease treatment

Clinical-stage biopharmaceutical company Alzheon has secured $100m in a Series E funding round to develop and commercialise ALZ-801/Valiltramiprosate, an oral …

NHS boss praises managers and leaders as Tories seek to scrap £1bn funding

The chief executive of the National Health Service (NHS) England spoke about her desire to ‘bolster management and leadership’ after …

FDA approves AstraZeneca’s Farxiga for paediatric T2D patients

The US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga (dapagliflozin) for the treatment of paediatric patients …